Mast cell‑mediated neuroinflammation may have a role in attention deficit hyperactivity disorder (Review)
- Authors:
- Yuchen Song
- Manqi Lu
- Haixia Yuan
- Tianyi Chen
- Xinmin Han
-
Affiliations: Institute of Pediatrics of Traditional Chinese Medicine, First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China - Published online on: May 25, 2020 https://doi.org/10.3892/etm.2020.8789
- Pages: 714-726
-
Copyright: © Song et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Thapar A and Cooper M: Attention deficit hyperactivity disorder. Lancet. 387:1240–1250. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Dalsgaard S, Ostergaard SD, Leckman JF, Mortensen PB and Pedersen MG: Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: A nationwide cohort study. Lancet. 385:2190–2196. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Howlett JR, Campbell-Sills L, Jain S, Heeringa SG, Nock MK, Sun X, Ursano RJ and Stein MB: Attention deficit hyperactivity disorder and risk of posttraumatic stress and related disorders: A prospective longitudinal evaluation in U.S. army soldiers. J Trauma Stress. 31:909–918. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ahmed R, Borst JM, Yong CW and Aslani P: Do parents of children with attention-deficit/hyperactivity disorder (ADHD) receive adequate information about the disorder and its treatments? A qualitative investigation. Patient Prefer Adherence. 8:661–670. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Hawi Z, Cummins TD, Tong J, Johnson B, Lau R, Samarrai W and Bellgrove MA: The molecular genetic architecture of attention deficit hyperactivity disorder. Mol Psychiatry. 20:289–297. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Posner J, Polanczyk GV and Sonuga-Barke E: Attention-deficit hyperactivity disorder. Lancet. 395:450–462. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Williams NM, Zaharieva I, Martin A, Langley K, Mantripragada K, Fossdal R, Stefansson H, Stefansson K, Magnusson P, Gudmundsson OO, et al: Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: A genome-wide analysis. Lancet. 376:1401–1408. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Thapar A, Cooper M, Eyre O and Langley K: What have we learnt about the causes of ADHD? J Child Psychol Psychiatry. 54:3–16. 2013. | |
|
Thompson JM, Waldie KE, Wall CR, Murphy R and Mitchell EA: ABC study group: Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years. PLoS One. 9(e108210)2014.PubMed/NCBI View Article : Google Scholar | |
|
Harold GT, Leve LD, Barrett D, Elam K, Neiderhiser JM, Natsuaki MN, Shaw DS, Reiss D and Thapar A: Biological and rearing mother influences on child ADHD symptoms: Revisiting the developmental interface between nature and nurture. J Child Psychol Psychiatry. 54:1038–1046. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Waltes R, Freitag CM, Herlt T, Lempp T, Seitz C, Palmason H, Meyer J and Chiocchetti AG: Impact of autism-associated genetic variants in interaction with environmental factors on ADHD comorbidities: An exploratory pilot study. J Neural Transm (Vienna). 126:1679–1693. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Grisham JR, Fullana MA, Mataix-Cols D, Moffitt TE, Caspi A and Poulton R: Risk factors prospectively associated with adult obsessive-compulsive symptom dimensions and obsessive-compulsive disorder. Psychol Med. 41:2495–2506. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Russell VA: Overview of animal models of attention deficit hyperactivity disorder (ADHD). Curr Protoc Neurosci. 9:9–35. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Hoogman M, Bralten J, Hibar DP, Mennes M, Zwiers MP, Schweren LSJ, van Hulzen KJE, Medland SE, Shumskaya E, Jahanshad N, et al: Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: A cross-sectional mega-analysis. Lancet Psychiatry. 4:310–319. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Gurkan K, Bilgic A, Turkoglu S, Kilic BG, Aysev A and Uslu R: Depression, anxiety and obsessive-compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment. J Psychopharmacol. 24:1810–1818. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Wilens TE: Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 28 (3 Suppl 2):S46–S53. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Lyman M, Lloyd DG, Ji X, Vizcaychipi MP and Ma D: Neuroinflammation: The role and consequences. Neurosci Res. 79:1–12. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Milo R, Korczyn AD, Manouchehri N and Stüve O: The temporal and causal relationship between inflammation and neurodegeneration in multiple sclerosis. Mult Scler. 4(1352458519886943)2019.PubMed/NCBI View Article : Google Scholar | |
|
Varley J, Brooks DJ and Edison P: Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions. Alzheimers Dement. 11:1110–1120. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Bradburn S, Murgatroyd C and Ray N: Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis. Ageing Res Rev. 50:1–8. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Jayaraj RL, Azimullah S, Beiram R, Jalal FY and Rosenberg GA: Neuroinflammation: Friend and foe for ischemic stroke. J Neuroinflammation. 16(142)2019.PubMed/NCBI View Article : Google Scholar | |
|
Woelfer M, Kasties V, Kahlfuss S and Walter M: The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder. Neuroscience. 403:93–110. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Matta SM, Hill-Yardin EL and Crack PJ: The influence of neuroinflammation in autism spectrum disorder. Brain Behav Immun. 79:75–90. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Calabrese V, Giordano J, Crupi R, Di Paola R, Ruggieri M, Bianchini R, Ontario ML, Cuzzocrea S and Calabrese EJ: Hormesis, cellular stress response and neuroinflammation in schizophrenia: Early onset versus late onset state. J Neurosci Res. 95:1182–1193. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Huh Y, Ji RR and Chen G: Neuroinflammation, bone marrow stem cells, and chronic pain. Front Immunol. 8(1014)2017.PubMed/NCBI View Article : Google Scholar | |
|
Lucas SM, Rothwell NJ and Gibson RM: The role of inflammation in CNS injury and disease. Br J Pharmacol. 147 (Suppl 1):S232–S240. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Skaper SD, Facci L, Zusso M and Giusti P: An inflammation-centric view of neurological disease: Beyond the neuron. Front Cell Neurosci. 12(72)2018.PubMed/NCBI View Article : Google Scholar | |
|
Colonna M and Butovsky O: Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 35:441–468. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Skaper SD, Giusti P and Facci L: Microglia and mast cells: Two tracks on the road to neuroinflammation. FASEB J. 26:3103–3117. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Zhang CJ, Jiang M, Zhou H, Liu W, Wang C, Kang Z, Han B, Zhang Q, Chen X, Xiao J, et al: TLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation. J Clin Invest. 128:5399–5412. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Xiong XY, Liu L and Yang QW: Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke. Prog Neurobiol. 142:23–44. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Colombo E and Farina C: Astrocytes: Key regulators of neuroinflammation. Trends Immunol. 37:608–620. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Montoya A, Elgueta D, Campos J, Chovar O, Falcón P, Matus S, Alfaro I, Bono MR and Pacheco R: Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation. J Neuroinflammation. 16(258)2019.PubMed/NCBI View Article : Google Scholar | |
|
Kempuraj D, Selvakumar GP, Thangavel R, Ahmed ME, Zaheer S, Raikwar SP, Iyer SS, Bhagavan SM, Beladakere-Ramaswamy S and Zaheer A: Mast cell activation in brain injury, stress, and post-traumatic stress disorder and Alzheimer's disease pathogenesis. Front Neurosci. 11(703)2017.PubMed/NCBI View Article : Google Scholar | |
|
Krystel-Whittemore M, Dileepan KN and Wood JG: Mast cell: A multi-functional master cell. Front Immunol. 6(620)2016.PubMed/NCBI View Article : Google Scholar | |
|
Gilfillan AM, Austin SJ and Metcalfe DD: Mast cell biology: Introduction and overview. Adv Exp Med Biol. 716:2–12. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Prussin C and Metcalfe DD: 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 111 (Suppl 2):S486–S494. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Vyas H and Krishnaswamy G: Paul Ehrlich's ‘Mastzellen’-from aniline dyes to DNA chip arrays: A historical review of developments in mast cell research. Methods Mol Biol. 315:3–11. 2006.PubMed/NCBI | |
|
Irani AM and Schwartz LB: Human mast cell heterogeneity. Allergy Proc. 15:303–308. 1994.PubMed/NCBI View Article : Google Scholar | |
|
da Silva EZ, Jamur MC and Oliver C: Mast cell function: A new vision of an old cell. J Histochem Cytochem. 62:698–738. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Polyzoidis S, Koletsa T, Panagiotidou S, Ashkan K and Theoharides TC: Mast cells in meningiomas and brain inflammation. J Neuroinflammation. 12(170)2015.PubMed/NCBI View Article : Google Scholar | |
|
Galli SJ and Tsai M: IgE and mast cells in allergic disease. Nat Med. 18:693–704. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Kritikou E, Kuiper J, Kovanen PT and Bot I: The impact of mast cells on cardiovascular diseases. Eur J Pharmacol. 778:103–115. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Sant GR, Kempuraj D, Marchand JE and Theoharides TC: The mast cell in interstitial cystitis: Role in pathophysiology and pathogenesis. Urology. 69 (Suppl 4):S34–S40. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Suurmond J, van der Velden D, Kuiper J, Bot I and Toes RE: Mast cells in rheumatic disease. Eur J Pharmacol. 778:116–124. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Theoharides TC, Donelan J, Kandere-Grzybowska K and Konstantinidou A: The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev. 49:65–76. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Theoharides TC, Angelidou A, Alysandratos KD, Zhang B, Asadi S, Francis K, Toniato E and Kalogeromitros D: Mast cell activation and autism. Biochim Biophys Acta. 1822:34–41. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Boyce JA: Mast cells and eicosanoid mediators: A system of reciprocal paracrine and autocrine regulation. Immunol Rev. 217:168–185. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Dong H, Wang Y, Zhang X, Zhang X, Qian Y, Ding H and Zhang S: Stabilization of brain mast cells alleviates LPS-induced neuroinflammation by inhibiting microglia activation. Front Cell Neurosci. 13(191)2019.PubMed/NCBI View Article : Google Scholar | |
|
Forsythe P: Mast cells in neuroimmune interactions. Trends Neurosci. 42:43–55. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Theoharides TC, Kempuraj D, Tagen M, Conti P and Kalogeromitros D: Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev. 217:65–78. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Theoharides TC and Cochrane DE: Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol. 146:1–12. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Theoharides TC, Sieghart W, Greengard P and Douglas WW: Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science. 207:80–82. 1980.PubMed/NCBI View Article : Google Scholar | |
|
Dvorak AM: Basophils and mast cells: Piecemeal degranulation in situ and ex vivo: A possible mechanism for cytokine-induced function in disease. Immunol Ser. 57:169–271. 1992.PubMed/NCBI | |
|
Pang X, Letourneau R, Rozniecki JJ, Wang L and Theoharides TC: Definitive characterization of rat hypothalamic mast cells. Neuroscience. 73:889–902. 1996.PubMed/NCBI View Article : Google Scholar | |
|
van Haaster CM, Engels W, Lemmens PJ, Hornstra G, van der Vusse GJ and Heemskerk JW: Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells: Roles of cytosolic calcium and protein tyrosine kinases. Biochim Biophys Acta. 1265:79–88. 1995.PubMed/NCBI View Article : Google Scholar | |
|
Lee CC, Avalos AM and Ploegh HL: Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol. 12:168–179. 2012.PubMed/NCBI View Article : Google Scholar | |
|
McCurdy JD, Olynych TJ, Maher LH and Marshall JS: Cutting edge: Distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol. 170:1625–1629. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Sismanopoulos N, Delivanis DA, Alysandratos KD, Angelidou A, Therianou A, Kalogeromitros D and Theoharides TC: Mast cells in allergic and inflammatory diseases. Curr Pharm Des. 18:2261–2277. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Cao J, Cetrulo CL and Theoharides TC: Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway. Mol Pharmacol. 69:998–1006. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Alysandratos KD, Asadi S, Angelidou A, Zhang B, Sismanopoulos N, Yang H, Critchfield A and Theoharides TC: Neurotensin and CRH interactions augment human mast cell activation. PLoS One. 7(e48934)2012.PubMed/NCBI View Article : Google Scholar | |
|
Kandere-Grzybowska K, Letourneau R, Kempuraj D, Donelan J, Poplawski S, Boucher W, Athanassiou A and Theoharides TC: IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol. 171:4830–4836. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Bawazeer MA and Theoharides TC: IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-kB, inhibited by methoxyluteolin. Eur J Pharmacol. 865(172760)2019.PubMed/NCBI View Article : Google Scholar | |
|
Theoharides TC and Leeman SE: Effect of IL-33 on de novo synthesized mediators from human mast cells. J Allergy Clin Immunol. 143(451)2019.PubMed/NCBI View Article : Google Scholar | |
|
Taracanova A, Tsilioni I, Conti P, Norwitz ER, Leeman SE and Theoharides TC: Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin. Proc Natl Acad Sci USA. 115:E9381–E9390. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Drube S, Kraft F, Dudeck J, Muller AL, Weber F, Gopfert C, Meininger I, Beyer M, Irmler I, Hafner N, et al: MK2/3 are pivotal for IL-33-induced and mast cell-dependent leukocyte recruitment and the resulting skin inflammation. J Immunol. 197:3662–3668. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Gasque P, Singhrao SK, Neal JW, Gotze O and Morgan BP: Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Pathol. 150:31–41. 1997.PubMed/NCBI | |
|
Pundir P, MacDonald CA and Kulka M: The novel receptor C5aR2 is required for C5a-mediated human mast cell adhesion, migration, and proinflammatory mediator production. J Immunol. 195:2774–2787. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Yuan B, Fu F, Huang S, Lin C, Yang G, Ma K, Shi H and Yang Z: C5a/C5aR pathway plays a vital role in brain inflammatory injury via initiating fgl-2 in intracerebral hemorrhage. Mol Neurobiol. 54:6187–6197. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Perkins DJ and Vogel SN: Inflammation: Species-specific TLR signalling-insight into human disease. Nat Rev Rheumatol. 12:198–200. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Skaper SD: Impact of Inflammation on the blood-neural barrier and blood-nerve interface: From review to therapeutic preview. Int Rev Neurobiol. 137:29–45. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Yasuoka S, Kawanokuchi J, Parajuli B, Jin S, Doi Y, Noda M, Sonobe Y, Takeuchi H, Mizuno T and Suzumura A: Production and functions of IL-33 in the central nervous system. Brain Res. 1385:8–17. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Burnstock G, Krugel U, Abbracchio MP and Illes P: Purinergic signalling: From normal behaviour to pathological brain function. Prog Neurobiol. 95:229–274. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Chakraborty S, Kaushik DK, Gupta M and Basu A: Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res. 88:1615–1631. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Kempuraj D, Thangavel R, Selvakumar GP, Ahmed ME, Zaheer S, Raikwar SP, Zahoor H, Saeed D, Dubova I, Giler G, et al: Mast cell proteases activate astrocytes and glia-neurons and release interleukin-33 by activating p38 and ERK1/2 MAPKs and NF-κB. Mol Neurobiol. 56:1681–1693. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang S, Zeng X, Yang H, Hu G and He S: Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling. Cell Physiol Biochem. 29:931–940. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Pietrzak A, Wierzbicki M, Wiktorska M and Brzezinska-Blaszczyk E: Surface TLR2 and TLR4 expression on mature rat mast cells can be affected by some bacterial components and proinflammatory cytokines. Mediators Inflamm. 2011(427473)2011.PubMed/NCBI View Article : Google Scholar | |
|
Zhang H, Lin L, Yang H, Zhang Z, Yang X, Zhang L and He S: Induction of IL-13 production and upregulation of gene expression of protease activated receptors in P815 cells by IL-6. Cytokine. 50:138–145. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Zhang H, Yang H and He S: TNF increases expression of IL-4 and PARs in mast cells. Cell Physiol Biochem. 26:327–336. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Wang X, Li C, Chen Y, Hao Y, Zhou W, Chen C and Yu Z: Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1alpha activation. Biochem Biophys Res Commun. 371:283–288. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Wang Y, Huang J, Li Y and Yang GY: Roles of chemokine CXCL12 and its receptors in ischemic stroke. Curr Drug Targets. 13:166–172. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Dong Y and Benveniste EN: Immune function of astrocytes. Glia. 36:180–190. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Kim DY, Hong GU and Ro JY: Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J Neuroinflammation. 8(25)2011.PubMed/NCBI View Article : Google Scholar | |
|
Seeldrayers PA, Levin LA and Johnson D: Astrocytes support mast cell viability in vitro. J Neuroimmunol. 36:239–243. 1992.PubMed/NCBI View Article : Google Scholar | |
|
Dong H, Zhang W, Zeng X, Hu G, Zhang H, He S and Zhang S: Histamine induces upregulated expression of histamine receptors and increases release of inflammatory mediators from microglia. Mol Neurobiol. 49:1487–1500. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Mele T and Juric DM: Identification and pharmacological characterization of the histamine H3 receptor in cultured rat astrocytes. Eur J Pharmacol. 720:198–204. 2013.PubMed/NCBI | |
|
Medic N, Vita F, Abbate R, Soranzo MR, Pacor S, Fabbretti E, Borelli V and Zabucchi G: Mast cell activation by myelin through scavenger receptor. J Neuroimmunol. 200:27–40. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Zhang S, Dong H, Zhang X, Li N, Sun J and Qian Y: Cerebral mast cells contribute to postoperative cognitive dysfunction by promoting blood brain barrier disruption. Behav Brain Res. 298(Pt B):158–166. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Dong H, Zhang X, Wang Y, Zhou X, Qian Y and Zhang S: Suppression of brain mast cells degranulation inhibits microglial activation and central nervous system inflammation. Mol Neurobiol. 54:997–1007. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Kempuraj D, Selvakumar GP, Thangavel R, Ahmed ME, Zaheer S, Kumar KK, Yelam A, Kaur H, Dubova I, Raikwar SP, et al: Glia maturation factor and mast cell-dependent expression of inflammatory mediators and proteinase activated receptor-2 in neuroinflammation. J Alzheimers Dis. 66:1117–1129. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Hagiyama M, Furuno T, Hosokawa Y, Iino T, Ito T, Inoue T, Nakanishi M, Murakami Y and Ito A: Enhanced nerve-mast cell interaction by a neuronal short isoform of cell adhesion molecule-1. J Immunol. 186:5983–5992. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Wilhelm M, Silver R and Silverman AJ: Central nervous system neurons acquire mast cell products via transgranulation. Eur J Neurosci. 22:2238–2248. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Kulka M, Sheen CH, Tancowny BP, Grammer LC and Schleimer RP: Neuropeptides activate human mast cell degranulation and chemokine production. Immunology. 123:398–410. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Masini E, Fantozzi R, Conti A, Blandina P, Brunelleschi S and Mannaioni PF: Mast cell heterogeneity in response to cholinergic stimulation. Int Arch Allergy Appl Immunol. 77:184–185. 1985.PubMed/NCBI View Article : Google Scholar | |
|
Skaper SD, Facci L, Kee WJ and Strijbos PJ: Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurones: A possible role for mast cells. J Neurochem. 76:47–55. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Ossovskaya VS and Bunnett NW: Protease-activated receptors: Contribution to physiology and disease. Physiol Rev. 84:579–621. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Claes SJ: Corticotropin-releasing hormone (CRH) in psychiatry: From stress to psychopathology. Ann Med. 36:50–61. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Karagkouni A, Alevizos M and Theoharides TC: Effect of stress on brain inflammation and multiple sclerosis. Autoimmun Rev. 12:947–953. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Cao J, Papadopoulou N, Kempuraj D, Boucher WS, Sugimoto K, Cetrulo CL and Theoharides TC: Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol. 174:7665–7675. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Cao J, Boucher W, Kempuraj D, Donelan JM and Theoharides TC: Acute stress and intravesical corticotropin-releasing hormone induces mast cell dependent vascular endothelial growth factor release from mouse bladder explants. J Urol. 176:1208–1213. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Rozniecki JJ, Sahagian GG, Kempuraj D, Tao K, Jocobson S, Zhang B and Theoharides TC: Brain metastases of mouse mammary adenocarcinoma is increased by acute stress. Brain Res. 1366:204–210. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Kritas SK, Caraffa A, Antinolfi P, Saggini A, Pantalone A, Rosati M, Tei M, Speziali A, Saggini R, Pandolfi F, et al: Nerve growth factor interactions with mast cells. Int J Immunopathol Pharmacol. 27:15–19. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Kempuraj D, Mentor S, Thangavel R, Ahmed ME, Selvakumar GP, Raikwar SP, Dubova I, Zaheer S, Iyer SS and Zaheer A: Mast cells in stress, pain, blood-brain barrier, neuroinflammation and Alzheimer's disease. Front Cell Neurosci. 13(54)2019.PubMed/NCBI View Article : Google Scholar | |
|
Papadopoulou NG, Oleson L, Kempuraj D, Donelan J, Cetrulo CL and Theoharides TC: Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells. J Mol Endocrinol. 35:R1–R8. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Ayyadurai S, Gibson AJ, D'Costa S, Overman EL, Sommerville LJ, Poopal AC, Mackey E, Li Y and Moeser AJ: Frontline science: Corticotropin-releasing factor receptor subtype 1 is a critical modulator of mast cell degranulation and stress-induced pathophysiology. J Leukoc Biol. 102:1299–1312. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Kempuraj D, Papadopoulou NG, Lytinas M, Huang M, Kandere-Grzybowska K, Madhappan B, Boucher W, Christodoulou S, Athanassiou A and Theoharides TC: Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology. 145:43–48. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Kempuraj D, Thangavel R, Selvakumar GP, Zaheer S, Ahmed ME, Raikwar SP, Zahoor H, Saeed D, Natteru PA, Iyer S and Zaheer A: Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration. Front Cell Neurosci. 11(216)2017.PubMed/NCBI View Article : Google Scholar | |
|
Pedersen WA, McCullers D, Culmsee C, Haughey NJ, Herman JP and Mattson MP: Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol Dis. 8:492–503. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Morgese MG, Schiavone S and Trabace L: Emerging role of amyloid beta in stress response: Implication for depression and diabetes. Eur J Pharmacol. 817:22–29. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Zhang C and Rissman RA: Corticotropin-releasing factor receptor-1 modulates biomarkers of DNA oxidation in Alzheimer's disease mice. PLoS One. 12(e181367)2017.PubMed/NCBI View Article : Google Scholar | |
|
Asadi S and Theoharides TC: Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin. J Neuroinflammation. 9(85)2012.PubMed/NCBI View Article : Google Scholar | |
|
de Pablos RM, Herrera AJ, Espinosa-Oliva AM, Sarmiento M, Munoz MF, Machado A and Venero JL: Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation. J Neuroinflammation. 11(34)2014.PubMed/NCBI View Article : Google Scholar | |
|
Strbian D, Kovanen PT, Karjalainen-Lindsberg ML, Tatlisumak T and Lindsberg PJ: An emerging role of mast cells in cerebral ischemia and hemorrhage. Ann Med. 41:438–450. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Profaci CP, Munji RN, Pulido RS and Daneman R: The blood-brain barrier in health and disease: Important unanswered questions. J Exp Med. 217(e20190062)2020.PubMed/NCBI View Article : Google Scholar | |
|
Silver R and Curley JP: Mast cells on the mind: New insights and opportunities. Trends Neurosci. 36:513–521. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Skaper SD: Mast cell-glia dialogue in chronic pain and neuropathic pain: Blood-brain barrier implications. CNS Neurol Disord Drug Targets. 15:1072–1078. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Lindsberg PJ, Strbian D and Karjalainen-Lindsberg ML: Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab. 30:689–702. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Tchougounova E, Lundequist A, Fajardo I, Winberg JO, Abrink M and Pejler G: A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem. 280:9291–9296. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Lapilover EG, Lippmann K, Salar S, Maslarova A, Dreier JP, Heinemann U and Friedman A: Peri-infarct blood-brain barrier dysfunction facilitates induction of spreading depolarization associated with epileptiform discharges. Neurobiol Dis. 48:495–506. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Mattila OS, Strbian D, Saksi J, Pikkarainen TO, Rantanen V, Tatlisumak T and Lindsberg PJ: Cerebral mast cells mediate blood-brain barrier disruption in acute experimental ischemic stroke through perivascular gelatinase activation. Stroke. 42:3600–3605. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Christy AL, Walker ME, Hessner MJ and Brown MA: Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. J Autoimmun. 42:50–61. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Rochfort KD and Cummins PM: Cytokine-mediated dysregulation of zonula occludens-1 properties in human brain microvascular endothelium. Microvasc Res. 100:48–53. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Liu H, Luiten PG, Eisel UL, Dejongste MJ and Schoemaker RG: Depression after myocardial infarction: TNF-α-induced alterations of the blood-brain barrier and its putative therapeutic implications. Neurosci Biobehav Rev. 37:561–572. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Esposito P, Gheorghe D, Kandere K, Pang X, Connolly R, Jacobson S and Theoharides TC: Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 888:117–127. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Alvarez JI, Cayrol R and Prat A: Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta. 1812:252–264. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R and Zlokovic BV: Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. 68:409–427. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Henkel JS, Beers DR, Wen S, Bowser R and Appel SH: Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology. 72:1614–1616. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Khalil MH, Silverman AJ and Silver R: Mast cells in the rat brain synthesize gonadotropin-releasing hormone. J Neurobiol. 56:113–124. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Corrigan F, Mander KA, Leonard AV and Vink R: Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation. J Neuroinflammation. 13(264)2016.PubMed/NCBI View Article : Google Scholar | |
|
Theoharides TC, Asadi S and Patel AB: Focal brain inflammation and autism. J Neuroinflammation. 10(46)2013.PubMed/NCBI View Article : Google Scholar | |
|
Strbian D, Karjalainen-Lindsberg ML, Tatlisumak T and Lindsberg PJ: Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. J Cereb Blood Flow Metab. 26:605–612. 2006.PubMed/NCBI View Article : Google Scholar | |
|
van der Schans J, Pleiter JC, de Vries TW, Schuiling-Veninga CC, Bos JH, Hoekstra PJ and Hak E: Association between medication prescription for atopic diseases and attention-deficit/hyperactivity disorder. Ann Allergy Asthma Immunol. 117:186–191. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Genuneit J, Braig S, Brandt S, Wabitsch M, Florath I, Brenner H and Rothenbacher D: Infant atopic eczema and subsequent attention-deficit/hyperactivity disorder-a prospective birth cohort study. Pediatr Allergy Immunol. 25:51–56. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Allred EN, Dammann O, Fichorova RN, Hooper SR, Hunter SJ, Joseph RM, Kuban K, Leviton A, O'Shea TM and Scott MN: ELGAN Study ADHD symptoms writing group for the ELGAN Study Investigators: Systemic inflammation during the first postnatal month and the risk of attention deficit hyperactivity disorder characteristics among 10 year-old children born extremely preterm. J Neuroimmune Pharmacol. 12:531–543. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Nielsen PR, Benros ME and Dalsgaard S: Associations between autoimmune diseases and attention-deficit/hyperactivity disorder: A nationwide study. J Am Acad Child Adolesc Psychiatry. 56:234–240. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Hegvik TA, Instanes JT, Haavik J, Klungsoyr K and Engeland A: Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: A population-based cross-sectional study. Eur Child Adolesc Psychiatry. 27:663–675. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Wang LJ, Yu YH, Fu ML, Yeh WT, Hsu JL, Yang YH, Chen WJ, Chiang BL and Pan WH: Attention deficit-hyperactivity disorder is associated with allergic symptoms and low levels of hemoglobin and serotonin. Sci Rep. 8(10229)2018.PubMed/NCBI View Article : Google Scholar | |
|
Segman RH, Meltzer A, Gross-Tsur V, Kosov A, Frisch A, Inbar E, Darvasi A, Levy S, Goltser T, Weizman A and Galili-Weisstub E: Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder. Mol Psychiatry. 7:72–74. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Ribases M, Hervas A, Ramos-Quiroga JA, Bosch R, Bielsa A, Gastaminza X, Fernandez-Anguiano M, Nogueira M, Gomez-Barros N, Valero S, et al: Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol Psychiatry. 63:935–945. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Cortese S and Vincenzi B: Obesity and ADHD: Clinical and neurobiological implications. Curr Top Behav Neurosci. 9:199–218. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Cortese S, Angriman M, Comencini E, Vincenzi B and Maffeis C: Association between inflammatory cytokines and ADHD symptoms in children and adolescents with obesity: A pilot study. Psychiatry Res. 278:7–11. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Boyle CA, Boulet S, Schieve LA, Cohen RA, Blumberg SJ, Yeargin-Allsopp M, Visser S and Kogan MD: Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics. 127:1034–1042. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Olfson M, Blanco C, Wang S, Laje G and Correll CU: National trends in the mental health care of children, adolescents, and adults by office-based physicians. JAMA Psychiatry. 71:81–90. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Rivera HM, Christiansen KJ and Sullivan EL: The role of maternal obesity in the risk of neuropsychiatric disorders. Front Neurosci. 9(194)2015.PubMed/NCBI View Article : Google Scholar | |
|
Sullivan EL, Riper KM, Lockard R and Valleau JC: Maternal high-fat diet programming of the neuroendocrine system and behavior. Horm Behav. 76:153–161. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P and Theoharides TC: Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation Clin. Ther. 37:984–995. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Anand D, Colpo GD, Zeni G, Zeni CP and Teixeira AL: Attention-deficit/hyperactivity disorder and inflammation: What does current knowledge tell Us? A systematic review. Front Psychiatry. 8(228)2017.PubMed/NCBI View Article : Google Scholar | |
|
Darwish AH, Elgohary TM and Nosair NA: Serum interleukin-6 level in children with attention-deficit hyperactivity disorder (ADHD). J Child Neurol. 34:61–67. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Donfrancesco R, Nativio P, Borrelli E, Giua E, Andriola E, Villa MP and DI Trani M: Serum cytokines in paediatric neuropsychiatric syndromes: Focus on attention deficit hyperactivity disorder. Minerva Pediatr: 2016 (Epub ahead of print). | |
|
O'Shea TM, Joseph RM, Kuban KC, Allred EN, Ware J, Coster T, Fichorova RN, Dammann O and Leviton A: ELGAN Study Investigators: Elevated blood levels of inflammation-related proteins are associated with an attention problem at age 24 mo in extremely preterm infants. Pediatr Res. 75:781–787. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Donfrancesco R, Nativio P, Di Benedetto A, Villa MP, Andriola E, Melegari MG, Cipriano E and Di Trani M: Anti-yo antibodies in children with ADHD: First results about serum cytokines. J Atten Disord 2016 (Epub ahead of print). | |
|
Oades RD, Dauvermann MR, Schimmelmann BG, Schwarz MJ and Myint AM: Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism-effects of medication. Behav Brain Funct. 6(29)2010.PubMed/NCBI View Article : Google Scholar | |
|
Rand KM, Austin NC, Inder TE, Bora S and Woodward LJ: Neonatal infection and later neurodevelopmental risk in the very preterm infant. J Pediatr. 170:97–104. 2016.PubMed/NCBI View Article : Google Scholar | |
|
van Tilborg E, Heijnen CJ, Benders MJ, van Bel F, Fleiss B, Gressens P and Nijboer CH: Impaired oligodendrocyte maturation in preterm infants: Potential therapeutic targets. Prog Neurobiol. 136:28–49. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Vogel SWN, Bijlenga D, Verduijn J, Bron TI, Beekman ATF, Kooij JJS and Penninx BWJH: Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers. Psychoneuroendocrinology. 79:31–39. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Chudal R, Brown AS, Gyllenberg D, Hinkka-Yli-Salomaki S, Sucksdorff M, Surcel HM, Upadhyaya S and Sourander A: Maternal serum C-reactive protein (CRP) and offspring attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 29:239–247. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kozlowska A, Wojtacha P, Rowniak M, Kolenkiewicz M and Huang ACW: ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats. Psychopharmacology (Berl). 236:2937–2958. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Saedisomeolia A, Samadi M, Gholami F, Seyedi M, Effatpanah M, Hashemi R, Abdolahi M and Honarvar NM: Vitamin d's molecular action mechanism in attention-deficit/ hyperactivity disorder: A review of evidence. CNS Neurol Disord Drug Targets. 17:280–290. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Verlaet AAJ, Maasakkers CM, Hermans N and Savelkoul HFJ: Rationale for dietary antioxidant treatment of ADHD. Nutrients. 10(E405)2018.PubMed/NCBI View Article : Google Scholar | |
|
Cortese S and Angriman M: Attention-deficit/hyperactivity disorder, iron deficiency, and obesity: Is there a link? Postgrad Med. 126:155–170. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Kean JD, Camfield D, Sarris J, Kras M, Silberstein R, Scholey A and Stough C: A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: Study protocol ACTRN12610000978066. Nutr J. 12(100)2013.PubMed/NCBI View Article : Google Scholar | |
|
Ghunaim N, Gronlund H, Kronqvist M, Gronneberg R, Soderstrom L, Ahlstedt S and van Hage-Hamsten M: Antibody profiles and self-reported symptoms to pollen-related food allergens in grass pollen-allergic patients from northern Europe. Allergy. 60:185–191. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Zhou L, Chen L, Li X, Li T, Dong Z and Wang YT: Food allergy induces alteration in brain inflammatory status and cognitive impairments. Behav Brain Res. 364:374–382. 2019.PubMed/NCBI View Article : Google Scholar | |
|
de Theije CG, Bavelaar BM, Lopes da Silva S, Korte SM, Olivier B, Garssen J and Kraneveld AD: Food allergy and food-based therapies in neurodevelopmental disorders. Pediatr Allergy Immunol. 25:218–226. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Sarlus H, Höglund CO, Karshikoff B, Wang X, Lekander M, Schultzberg M and Oprica M: Allergy influences the inflammatory status of the brain and enhances tau-phosphorylation. J Cell Mol Med. 16:2401–2412. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Niggemann B, Reibel S, Roehr CC, Felger D, Ziegert M, Sommerfeld C and Wahn U: Predictors of positive food challenge outcome in non-IgE-mediated reactions to food in children with atopic dermatitis. J Allergy Clin Immunol. 108:1053–1058. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Milosz M, Demkow U and Wolanczyk T: Relation between attention-deficit hyperactivity disorder and IgE-dependent allergy in pediatric patients. Adv Exp Med Biol. 1096:105–109. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Jiang X, Shen C, Dai Y, Jiang F, Li S, Shen X, Hu Y and Li F: Early food allergy and respiratory allergy symptoms and attention-deficit/hyperactivity disorder in Chinese children: A cross-sectional study. Pediatr Allergy Immunol. 29:402–409. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Boris M and Mandel FS: Foods and additives are common causes of the attention deficit hyperactive disorder in children. Ann Allergy. 72:462–468. 1994.PubMed/NCBI | |
|
Verlaet AA, Noriega DB, Hermans N and Savelkoul HF: Nutrition, immunological mechanisms and dietary immunomodulation in ADHD. Eur Child Adolesc Psychiatry. 23:519–529. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Ritz BW and Lord RS: Case study: The effectiveness of a dietary supplement regimen in reducing IgG-mediated food sensitivity in ADHD. Altern Ther Health Med. 11:72–75. 2005.PubMed/NCBI | |
|
Miyazaki C, Koyama M, Ota E, Swa T, Mlunde LB, Amiya RM, Tachibana Y, Yamamoto-Hanada K and Mori R: Allergic diseases in children with attention deficit hyperactivity disorder: A systematic review and meta-analysis. BMC Psychiatry. 17(120)2017.PubMed/NCBI View Article : Google Scholar | |
|
Johnston LK, Chien KB and Bryce PJ: The immunology of food allergy. J Immunol. 192:2529–2534. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Pelsser LM, Buitelaar JK and Savelkoul HF: ADHD as a (non) allergic hypersensitivity disorder: A hypothesis. Pediatr Allergy Immunol. 20:107–112. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Suwan P, Akaramethathip D and Noipayak P: Association between allergic sensitization and attention deficit hyperactivity disorder (ADHD). Asian Pac J Allergy Immunol. 29:57–65. 2011.PubMed/NCBI | |
|
Rijnierse A, Nijkamp FP and Kraneveld AD: Mast cells and nerves tickle in the tummy: Implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacol Ther. 116:207–235. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Gui XY: Mast cells: A possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable bowel syndrome. J Gastroenterol Hepatol. 13:980–989. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH and Kishimoto T: Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA. 82:5490–5494. 1985.PubMed/NCBI View Article : Google Scholar | |
|
Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T and Malik M: Elevated immune response in the brain of autistic patients. J Neuroimmunol. 207:111–116. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Needham BD, Tang W and Wu WL: Searching for the gut microbial contributing factors to social behavior in rodent models of autism spectrum disorder. Dev Neurobiol. 78:474–499. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Meeking MM, MacFabe DF, Mepham JR, Foley KA, Tichenoff LJ, Boon FH, Kavaliers M and Ossenkopp KP: Propionic acid induced behavioural effects of relevance to autism spectrum disorder evaluated in the hole board test with rats. Prog Neuropsychopharmacol Biol Psychiatry. 97(109794)2020.PubMed/NCBI View Article : Google Scholar | |
|
Zass LJ, Hart SA, Seedat S, Hemmings SM and Malan-Muller S: Neuroinflammatory genes associated with post-traumatic stress disorder: Implications for comorbidity. Psychiatr Genet. 27:1–16. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Nakamura Y, Ishimaru K, Shibata S and Nakao A: Regulation of plasma histamine levels by the mast cell clock and its modulation by stress. Sci Rep. 7(39934)2017.PubMed/NCBI View Article : Google Scholar | |
|
Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, Quevedo J, Salum G, Magalhaes PV, Kapczinski F and Kauer-Sant'Anna M: Inflammatory markers in post-traumatic stress disorder: A systematic review, meta-analysis, and meta-regression. Lancet Psychiatry. 2:1002–1012. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Geracioti TD Jr, Carpenter LL, Owens MJ, Baker DG, Ekhator NN, Horn PS, Strawn JR, Sanacora G, Kinkead B, Price LH and Nemeroff CB: Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression. Am J Psychiatry. 163:637–643. 2006.PubMed/NCBI View Article : Google Scholar | |
|
O'Donovan A, Cohen BE, Seal KH, Bertenthal D, Margaretten M, Nishimi K and Neylan TC: Elevated risk for autoimmune disorders in Iraq and afghanistan veterans with posttraumatic stress disorder. Biol Psychiatry. 77:365–374. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Hendriksen E, van Bergeijk D, Oosting RS and Redegeld FA: Mast cells in neuroinflammation and brain disorders. Neurosci Biobehav Rev. 79:119–133. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Ahmed ME, Iyer S, Thangavel R, Kempuraj D, Selvakumar GP, Raikwar SP, Zaheer S and Zaheer A: Co-localization of glia maturation factor with NLRP3 inflammasome and autophagosome markers in human Alzheimer's disease brain. J Alzheimers Dis. 60:1143–1160. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Xiong Z, Thangavel R, Kempuraj D, Yang E, Zaheer S and Zaheer A: Alzheimer's disease: Evidence for the expression of interleukin-33 and its receptor ST2 in the brain. J Alzheimers Dis. 40:297–308. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Shaik-Dasthagirisaheb YB and Conti P: The role of mast cells in Alzheimer's disease. Adv Clin Exp Med. 25:781–787. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Tagen M, Elorza A, Kempuraj D, Boucher W, Kepley CL, Shirihai OS and Theoharides TC: Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content. J Immunol. 183:6313–6319. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Nelson RB, Siman R, Iqbal MA and Potter H: Identification of a chymotrypsin-like mast cell protease in rat brain capable of generating the N-terminus of the Alzheimer amyloid beta-protein. J Neurochem. 61:567–577. 1993.PubMed/NCBI View Article : Google Scholar | |
|
Ibrahim MZ, Reder AT, Lawand R, Takash W and Sallouh-Khatib S: The mast cells of the multiple sclerosis brain. J Neuroimmunol. 70:131–138. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Russi AE and Brown MA: The meninges: New therapeutic targets for multiple sclerosis. Transl Res. 165:255–269. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Theoharides TC, Asadi S, Panagiotidou S and Weng Z: The ‘missing link’ in autoimmunity and autism: Extracellular mitochondrial components secreted from activated live mast cells. Autoimmun Rev. 12:1136–1142. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Kawasaki H, Chang HW, Tseng HC, Hsu SC, Yang SJ, Hung CH, Zhou Y and Huang SK: A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor. Allergy. 69:445–452. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Hermine O, Lortholary O, Leventhal PS, Catteau A, Soppelsa F, Baude C, Cohen-Akenine A, Palmerini F, Hanssens K, Yang Y, et al: Case-control cohort study of patients' perceptions of disability in mastocytosis. PLoS One. 3(e2266)2008.PubMed/NCBI View Article : Google Scholar | |
|
Georgin-Lavialle S, Moura DS, Salvador A, Chauvet-Gelinier JC, Launay JM, Damaj G, Cote F, Soucie E, Chandesris MO, Barete S, et al: Mast cells' involvement in inflammation pathways linked to depression: Evidence in mastocytosis. Mol Psychiatry. 21:1511–1516. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Couturier N, Zappulla JP, Lauwers-Cances V, Uro-Coste E, Delisle MB, Clanet M, Montagne L, Van der Valk P, Bö L and Liblau RS: Mast cell transcripts are increased within and outside multiple sclerosis lesions. J Neuroimmunol. 195:176–185. 2008.PubMed/NCBI View Article : Google Scholar |
